rhodamine 123 has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrens, CJ; Gabriel, S; Heinemann, U; Kann, O; Kovács, R; Lehmann, TN; Njunting, M; Otáhal, J | 1 |
| Gessler, P; Pavenstädt-Grupp, I; Schneckenburger, H | 1 |
2 other study(ies) available for rhodamine 123 and Metabolic Diseases
| Article | Year |
|---|---|
Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans.
Topics: Adult; Animals; Chronic Disease; Electric Stimulation; Epilepsy, Temporal Lobe; Female; Fluorescent Dyes; Hippocampus; Humans; Male; Membrane Potentials; Metabolic Diseases; Middle Aged; Mitochondria; Muscarinic Agonists; NADP; Neurons; Pilocarpine; Potassium; Rats; Rats, Wistar; Rhodamine 123; Sclerosis | 2005 |
Measurements of mitochondrial deficiencies in living cells by microspectrofluorometry.
Topics: Cells, Cultured; Fibroblasts; Humans; Metabolic Diseases; Mitochondria; Rhodamine 123; Rhodamines; Saccharomyces cerevisiae; Spectrometry, Fluorescence | 1992 |